Cochlear Ltd is an Australian company specializing in the design, manufacturing, and distribution of hearing implant systems. With its headquarters located in Sydney, Australia, the company was founded in 1981 by Professor Graeme Clark, who invented the world's first multi-channel cochlear implant. Cochlear's main product is the cochlear implant system, which helps individuals with severe to profound hearing loss regain or improve their hearing ability.

The implant consists of an external sound processor that captures sound, processes it, and transmits it to the internal implant, which stimulates the auditory nerve to send sound signals to the brain. The company also offers a range of accessories and hearing solutions to enhance the overall hearing experience for its users. Operating on a global scale, Cochlear has established a strong presence in the hearing implant industry.

The company has subsidiaries in over 20 countries, including the United States, Germany, Japan, and China. Cochlear has also formed partnerships and joint ventures with various organizations to expand its reach and improve patient outcomes. Notably, Cochlear has collaborated with ReSound, a leading hearing aid manufacturer, to develop advanced technologies and integrated solutions for individuals with both hearing loss and tinnitus.

Cochlear holds a significant market position in the global hearing implant industry. The company's global sales have been consistently strong, and it has a strong reputation for its technological innovations, clinical research, and commitment to improving the lives of people with hearing impairments. Cochlear operates in a competitive market, with rivals such as MED-EL and Advanced Bionics also vying for market share.

In recent years, Cochlear has achieved several significant milestones, including the launch of its Nucleus 7 Sound Processor, the world's first Made for iPhone cochlear implant sound processor. This advancement allows users to connect directly to their Apple devices, providing a seamless hearing experience. Such innovations have propelled the company's growth and solidified its position as a global leader in the industry.

As of the latest available information, Cochlear continues to develop and enhance its portfolio of hearing implant systems and technology. The company remains committed to expanding access to its life-changing solutions worldwide, and ongoing research and development efforts ensure that Cochlear maintains its position at the forefront of the hearing implant industry